October 11, 2023DrugsFDA
Amerisource Health Services LLC recalls HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Healt
Hazard: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
October 11, 2023DrugsFDA
Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382-
Hazard: Failed Dissolution Specifications
October 11, 2023DrugsFDA
Dr. Berne's Whole Health Products recalls Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM
Hazard: Non-Sterility
October 11, 2023DrugsFDA
Dr. Berne's Whole Health Products recalls Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM
Hazard: CGMP Deviations
October 11, 2023DrugsFDA
Dr. Berne's Whole Health Products recalls Dr. Berne's Organic Castor Oil Eye Drops, Net WT 30 mL/1 fl oz bottle, Distributed by: Dr. Berne's Whole Health Products
Hazard: CGMP Deviations
October 11, 2023DrugsFDA
Dr. Berne's Whole Health Products recalls Dr. Berne's MSM MIST 15% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM
Hazard: CGMP Deviations
October 11, 2023DrugsFDA
Dr. Berne's Whole Health Products recalls Dr. Berne's MSM DROPS 15% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, N
Hazard: CGMP Deviations
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 0.5 mg/5 mL, (0.1 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Servic
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, C
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc.,
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 5,000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook R
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dun
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Di
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Di
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 793
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 m
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy S
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility: